Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Merit (MMSI) Investors with Significant Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud

MMSI

SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges Merit Medical Systems, Inc. (NASDAQ: MMSI) investors who have suffered losses in excess of $50,000 to submit their losses now or contact the firm immediately to learn if they qualify to recover compensable damages.  The firm is investigating Merit and investors may have valuable claims against the Company and its senior management for violations of federal securities laws. 

Relevant Holding Period: Before Oct. 31, 2019
Sign Up: www.hbsslaw.com/investor-fraud/MMSI 
Contact An Attorney Now:MMSI@hbsslaw.com
 510-725-3000

Merit Medical Systems (MMSI) Investigation:

The investigation centers on whether Merit misled investors about its business and prospects.

On July 25, 2019, the Company announced disappointing Q2 2019 financial results and reduced FY 2019 revenue and earnings guidance. 

In response, the price of Merit shares plummeted $13.84, down 25% and wiping out over $750 million of the Company’s market capitalization.

Then, about 3 months later, on October 30, 2019, Merit announced disappointing Q3 2019 financial results, reduced FY 2019 guidance for the second time in 3 months, and withdrew 2020 guidance in its entirety.  Management blamed the results in part on the summer quarter generally being the slowest quarter of the year. 

In response, the price of Merit shares plummeted as much as $9.61, down 33% and wiping out over $530 million of the Company’s market capitalization during intraday trading on October 31, 2019.

“We’re focused on investors’ losses and the extent to which the Company’s and senior management’s statements may have been misleading,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

Whistleblowers: Persons with non-public information regarding Merit should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email MMSI@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today